Ryvu Therapeutics S.A./ PLSELVT00013 /
31/05/2024 7:57:31 | Diferencia +0.2800 | Volumen | Bid22:00:02 | Ask22:00:02 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
12.6600EUR | +2.26% | - Volumen de negocios: - |
12.0400Volumen de oferta: 340 | 13.4400Tamaño/ Volumen/ Formato de Ask: 340 | 292.23 millonesEUR | - | - |
GlobeNewswire
11:42
VENTYX SHAREHOLDER REMINDER: BFA Law Reminds Ventyx Biosciences, Inc. (NASDAQ: VTYX) Shareholders to...
GlobeNewswire
11:41
SQSP (NYSE) REMINDER: BFA Law Reminds Squarespace Shareholders to Inquire About Ongoing Investigatio...
GlobeNewswire
11:39
SPT (NYSE) FRAUD ALERT: Sprout Social, Inc. Investors who Lost Money when Stock Plummeted 40% are En...
GlobeNewswire
11:37
PATH (NYSE) INVESTOR ALERT: UiPath, Inc. Investigated for Securities Fraud After 34% Stock Drop, Con...
GlobeNewswire
11:36
CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation ...
GlobeNewswire
11:34
CAE (NYSE) INVESTOR ALERT: CAE, Inc. Investigated for Securities Fraud from Impairment Charges, Cont...
GlobeNewswire
11:33
BIIB (NASDAQ) FRAUD ALERT: Biogen Inc. Investors who Lost Money are Encouraged to Contact BFA Law ab...
GlobeNewswire
3:45
Cielo Announces Final Closing of Private Placement of Convertible Debenture Units
GlobeNewswire
3:00
VERADIGM ALERT: Bragar Eagel & Squire, P.C. is Investigating Veradigm Inc. on Behalf of Long-Term St...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página